In a significant scientific breakthrough, researchers have uncovered the first evidence of Alzheimer’s disease transmission in living individuals. A recent study published in Nature Medicine details a unique case where Alzheimer’s appears to have been transmitted medically through the amyloid-beta protein. This discovery challenges the traditional view of Alzheimer’s as primarily a sporadic or inherited condition, opening new pathways for understanding the disease.
Alzheimer’s disease is typically seen as either a condition of late adulthood or one resulting from genetic mutations. However, this study highlights an extraordinary scenario: the transmission of Alzheimer’s through a medical treatment involving a specific type of human growth hormone (c-hGH). This hormone, derived from pituitary glands of deceased individuals, was used between 1959 and 1985 to treat childhood short stature. In the UK alone, at least 1,848 people received c-hGH treatment during that period.
Continue reading… “Groundbreaking Discovery: Evidence of Alzheimer’s Transmission in Medical Cases”